simvastatin has been researched along with Epithelial Ovarian Cancer in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Glogova, A; Haagsma, J; Pereira, M; Petrik, J; Shepherd, TG; Stewart, J | 1 |
| Brodsky, AS; Casella, C; Lynch, K; Miller, DH | 1 |
| DiMattia, G; Greenaway, JB; Hardy, D; Osz, K; Petrik, J; Revay, T; Shepherd, T; Virtanen, C | 1 |
3 other study(ies) available for simvastatin and Epithelial Ovarian Cancer
| Article | Year |
|---|---|
Mutant p53 murine oviductal epithelial cells induce progression of high-grade serous carcinoma and are most sensitive to simvastatin therapy in vitro and in vivo.
Topics: Animals; Carcinoma, Ovarian Epithelial; Epithelial Cells; Fallopian Tubes; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mevalonic Acid; Mice; Ovarian Neoplasms; Simvastatin; Tumor Suppressor Protein p53 | 2023 |
Oxysterols synergize with statins by inhibiting SREBP-2 in ovarian cancer cells.
Topics: Apoptosis; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Survival; Drug Synergism; Drug Therapy, Combination; Female; Humans; Hydroxycholesterols; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Signal Transduction; Simvastatin; Sterol Regulatory Element Binding Protein 2 | 2014 |
Ovarian tumour growth is characterized by mevalonate pathway gene signature in an orthotopic, syngeneic model of epithelial ovarian cancer.
Topics: Animals; Apoptosis; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; Genomic Instability; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mevalonic Acid; Mice; Mice, Inbred C57BL; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Polyisoprenyl Phosphates; Simvastatin; Tumor Microenvironment | 2016 |